Merck & Co | PX14A6G: Notice of exempt solicitation
Merck & Co | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Merck & Co | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Merck & Co | 4: Statement of changes in beneficial ownership of securities-10% Owner Merck & Co., Inc.
Merck & Co | 10-K: Annual report
Merck & Co | 8-K: Peter C. Wendell Gave Notice to Merck & Co., Inc. Of His Intention to Retire from the Board of Directors of the Company as of the Company’s 2024 Annual Meeting of Shareholders on May 28, 2024
Merck & Co | 4: Statement of changes in beneficial ownership of securities-Officer Litchfield Caroline
Merck & Co | 4: Statement of changes in beneficial ownership of securities-Officer Davis Robert M
Merck & Co | 4: Statement of changes in beneficial ownership of securities-Officer Romanelli Joseph
Merck & Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Merck & Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Merck & Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Merck & Co | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(9.66%)
Merck & Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Merck & Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Merck & Co | 4: Statement of changes in beneficial ownership of securities-Officer Li Dean Y
Merck & Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Merck & Co | 4: Statement of changes in beneficial ownership of securities-Officer Williams David Michael
Merck & Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Merck & Co | 4: Statement of changes in beneficial ownership of securities-Officer Oosthuizen Johannes Jacobus
No Data